Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Shares withheld for taxes Head of Research gave up 345 shares (to pay taxes)
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Shares withheld for taxes Chief Accounting Officer gave up 8 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Planned sale Director sold 1,186 shares at an average $202.15 ($239,750)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Results of operations
  15. 4 Grant or award Director acquired 1,505 shares (grant or award)
  16. 4 Grant or award Director acquired 1,505 shares (grant or award)
  17. 4 Grant or award Director acquired 1,505 shares (grant or award)
  18. 4 Grant or award Director acquired 1,505 shares (grant or award)
  19. 4 Grant or award Director acquired 1,505 shares (grant or award)
  20. 4 Grant or award Director acquired 1,505 shares (grant or award)

Page 1 of 137 · 2,721 filings